Last edition
News about Clinical Trials
Transcenta Holding Limited, a global biotherapeutics company announced that the updated phase I clinical study (NCT04272944) data on the safety and efficacy of MSB2311, a pH-dependent PD-L1 antibody, in Chinese patients with advanced solid tumors and hematological malignancies have been presented as an abstract online publication
Clinical Trials | 21/05/2021 | By Darshana | 237
Biogen Inc. announced topline results from the phase 2/3 XIRIUS study of cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients with X-linked retinitis pigmentosa (XLRP)
Clinical Trials | 17/05/2021 | By Darshana | 730
ReGenTree LLC, a US joint venture company between GtreeBNT and RegeneRx announced results of additional analysis of the phase 3 clinical trial ARISE-3, using RGN-259 for the treatment of dry eye syndrome. The company also pooled data from all three phase 3 clinical trials for dry eye
Clinical Trials | 15/05/2021 | By Darshana | 383
Sun Pharma Advanced Research Company Ltd. (SPARC) reported positive top-line results from its phase 3 trial (CLR_16_33) for its investigational drug, PDP-716 ophthalmic suspension, for the treatment of open angle glaucoma or ocular hypertension
Clinical Trials | 14/05/2021 | By Darshana | 269
CNS Pharma completes manufacturing strategy for Berubicin to treat glioma brain tumors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and CNS, provided an update on the manufacturing strategy for Berubicin drug product, its lead drug candidate for the treatment of glioma brain tumors
Clinical Trials | 17/07/2020 | By Darshana | 614
China to run human coronavirus vaccine trial in UAE
China National Biotec Group (CNBG) has won approval to run a large-scale Phase 3 clinical trial of its novel coronavirus vaccine candidate in the United Arab Emirates (UAE), the company said. China is seeking to trial potential vaccines overseas because of a lack of new patients at home
Clinical Trials | 25/06/2020 | By Darshana | 425
Roche today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) and whose tumours had PTEN loss
Clinical Trials | 19/06/2020 | By Darshana | 380
The U.S. Food and Drug Administration has issued warning letters to three companies for marketing adulterated and misbranded COVID-19 antibody test
Clinical Trials | 18/06/2020 | By Darshana | 380
Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc
Clinical Trials | 28/05/2020 | By Darshana | 516
Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers in patients whose tumors have an alteration (mutation or fusion) in a specific gene
Clinical Trials | 10/05/2020 | By Darshana | 286
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy